F. Belussi

931 total citations
26 papers, 695 citations indexed

About

F. Belussi is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, F. Belussi has authored 26 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Hepatology and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in F. Belussi's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (8 papers). F. Belussi is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (8 papers). F. Belussi collaborates with scholars based in Italy and United States. F. Belussi's co-authors include A. Albertí, Patrizia Pontisso, Luisa Benvegnù, P Avogaro, G. Cazzolato, Giovanna Fattovich, Liliana Chemello, Luisa Cavalletto, Pietro Casarin and C. Casarin and has published in prestigious journals such as The Lancet, Hepatology and Journal of Hepatology.

In The Last Decade

F. Belussi

26 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Belussi Italy	10	531	510	86	74	56	26	695
Sonia Rossi Italy	11	742 1.4×	684 1.3×	54 0.6×	58 0.8×	51 0.9×	14	928
Mahmoud Khattab Egypt	14	650 1.2×	623 1.2×	72 0.8×	81 1.1×	44 0.8×	35	812
Nicola Alessi Italy	11	487 0.9×	421 0.8×	51 0.6×	38 0.5×	78 1.4×	21	642
Lydia L. Barlow United States	8	311 0.6×	284 0.6×	52 0.6×	40 0.5×	41 0.7×	10	486
Alessandro Vario Italy	10	709 1.3×	649 1.3×	40 0.5×	54 0.7×	54 1.0×	15	825
M. De Palma Italy	12	600 1.1×	513 1.0×	26 0.3×	56 0.8×	49 0.9×	29	914
Shinn‐Chern Chen Taiwan	17	672 1.3×	612 1.2×	50 0.6×	148 2.0×	64 1.1×	38	831
Jorge Daruich Argentina	12	429 0.8×	479 0.9×	73 0.8×	26 0.4×	101 1.8×	40	641
Joy Peter United States	12	536 1.0×	504 1.0×	62 0.7×	91 1.2×	87 1.6×	24	695
Stella De Nicola Italy	13	646 1.2×	583 1.1×	80 0.9×	86 1.2×	32 0.6×	29	726

Countries citing papers authored by F. Belussi

Since Specialization

Citations

This map shows the geographic impact of F. Belussi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Belussi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Belussi more than expected).

Fields of papers citing papers by F. Belussi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Belussi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Belussi. The network helps show where F. Belussi may publish in the future.

Co-authorship network of co-authors of F. Belussi

This figure shows the co-authorship network connecting the top 25 collaborators of F. Belussi. A scholar is included among the top collaborators of F. Belussi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Belussi. F. Belussi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brugnaro, Pierluigi, et al.. (2011). Sustained Remission of a Primary Nodal Merkel Cell Carcinoma in an HIV-Positive Patient. Onkologie. 34(4). 190–192. 7 indexed citations

Cavalletto, Luisa, Liliana Chemello, Carlo Donada, et al.. (2000). The pattern of response to interferon alpha (α-IFN) predicts sustained response to a 6-month α-IFN and ribavirin retreatment for chronic hepatitis C. Journal of Hepatology. 33(1). 128–134. 24 indexed citations

Chemello, L., Luisa Cavalletto, E. Bernardinello, et al.. (1998). Retreatment of chronic hepatitis C (CHC) with sequential interferon-ribavirin combination (IFN-RIBA) therapy. Journal of Hepatology. 28. 109–109. 7 indexed citations

Chemello, Liliana, Paola Bonetti, Luisa Cavalletto, et al.. (1995). Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. Hepatology. 22(3). 700–706. 157 indexed citations

Chemello, Liliana, Luisa Cavalletto, E. Bernardinello, et al.. (1995). Pilot study on the efficacy of intravenous natural ?-interferon therapy in Italian patients with chronic hepatitis C and relation to the HCV genotype. International Hepatology Communications. 3(5). 237–243. 8 indexed citations

Albertí, A., Patrizia Pontisso, L. Chemello, et al.. (1995). The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.. PubMed. 22(1 Suppl). 38–41. 99 indexed citations

Albertí, A., Liliana Chemello, Paola Bonetti, et al.. (1993). Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. Journal of Hepatology. 17. S123–S126. 64 indexed citations

Fattovich, Giovanna, Patrizia Farci, Massimo Rugge, et al.. (1992). A Randomized Controlled Trial of Lymphoblastoid Interferon–α in Patients With Chronic Hepatitis B Lacking Hbeag. Hepatology. 15(4). 584–589. 125 indexed citations

Albertí, A., Giovanna Fattovich, Patrizia Farci, et al.. (1990). Favourable response to lymphoblastoid interferon of anti-HBe and HBV-DNA positive chronic hepatitis B. 645–647. 3 indexed citations

10.

Chemello, Liliana, Luisa Benvegnù, F. Belussi, et al.. (1990). Pilot study of interferon alpha-2a therapy in preventing chronic evolution of acute hepatitis C. Journal of Hepatology. 11. S81–S81. 9 indexed citations

11.

Fattovich, G., P Farci, L. Brollo, et al.. (1989). Anti-HBe and HBV-DNA positive chronic hepatitis B: Response to interferon therapy. Journal of Hepatology. 9. S29–S29. 2 indexed citations

12.

Albertí, A., et al.. (1988). ANTIBODY RESPONSE TO PRE-S2 AND HEPATITIS B VIRUS INDUCED LIVER DAMAGE. The Lancet. 331(8600). 1421–1424. 61 indexed citations

13.

Avogaro, P, et al.. (1985). Lipids and Proteins of Lipoproteins in Human Atherosclerosis. PubMed. 40(10). 17–23. 1 indexed citations

14.

Avogaro, P, et al.. (1983). Relationships of body weight and fatness to lipoprotein components. Variations following hypocaloric diet.. PubMed. 19. 141–50. 1 indexed citations

15.

Avogaro, P, et al.. (1983). Variations in lipids and proteins of lipoproteins by fenofibrate in some hyperlipoproteinaemic states. Atherosclerosis. 47(1). 95–100. 14 indexed citations

16.

Avogaro, P, et al.. (1982). Altered apoprotein composition of HDL2 and HDL3 in chronic alcoholics.. PubMed. 10(5). 317–28. 12 indexed citations

17.

Avogaro, P, G. Cazzolato, Gabriele Bittolo Bon, F. Belussi, & G.B. Quinci. (1979). Values of apo-AI and apo-B in humans according to age and sex. Clinica Chimica Acta. 95(2). 311–315. 21 indexed citations

18.

Avogaro, P, et al.. (1977). Chemical composition of ultracentrifugal fractions in different patterns of human atherosclerosis. Atherosclerosis. 26(2). 163–172. 6 indexed citations

19.

Avogaro, P, G. Cazzolato, Gabriele Bittolo Bon, et al.. (1977). Modifications of lipids, lipoproteins and plasmatic apolipoproteins induced by a phospholipid extracted from calf heart. Pharmacological Research Communications. 9(9). 885–892. 1 indexed citations

20.

Avogaro, P, et al.. (1977). Effect of the extractive heparinoid, glucuronylglucosaminglycan sulfate (3-GS), on human plasma lipids. Pharmacological Research Communications. 9(10). 977–986. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact